Siga Technologies (SIGA) Net Cash Flow Growth (3y) (2013 - 2025)
Siga Technologies (SIGA) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 32.03% |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | 28.99% |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | 37.89% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | -49.94% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | 37.74% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | -41.05% |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | -62.71% |
| 10 | Siga Technologies | 228.06 Mn | 73.10 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.01% |
| Jun 30, 2025 | 36.11% |
| Mar 31, 2025 | -48.44% |
| Dec 31, 2024 | 75.87% |
| Sep 30, 2024 | -10.67% |
| Jun 30, 2024 | -66.20% |
| Mar 31, 2024 | 17.95% |
| Dec 31, 2023 | 26.30% |
| Sep 30, 2023 | -30.04% |
| Jun 30, 2023 | -17.53% |
| Mar 31, 2023 | 30.10% |
| Dec 31, 2022 | 10.41% |
| Sep 30, 2022 | -181.64% |
| Jun 30, 2022 | -107.29% |
| Mar 31, 2022 | 863.50% |
| Dec 31, 2021 | -47.74% |
| Sep 30, 2021 | -27.38% |
| Jun 30, 2021 | -15.43% |
| Mar 31, 2021 | -9.89% |
| Dec 31, 2020 | 87.54% |